Orthopaedic Implants Worth Rs 70L Seized By FDA

Nagpur: The Food and Drug Administration (FDA) team seized orthopaedic implants worth around Rs 70 lakh from a stockist during a raid at Dhantoli last week. The implants, mostly imported, were stocked without licences.

The team, under supervision of FDA joint commissioner (drug), Viraj Paunikar, served a notice to the stockist to furnish bills and invoices within three days.

The team comprising drug inspectors Neeraj Lohkare, Prashant Ramteke, Manish Chaudhuri and Shehnaz Taji acted on a tip-off and took action.

“If the stockist provides us bills and invoices, only then the seized materials would be considered legally procured items, else there he would be prosecuted for the irregularity,” said an official adding most of the seized implants were meant to be sent to different private hospitals.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16